At a glance
ClinicalIndex Comparison RecordN/ACompleted· 55 enrolled
Drug / intervention
2-way pager +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
2-Way Pagers to Improve Schizophrenia Medication Adherence
In Brief
A clinical study evaluating 2-way pager and Treatment as usual for Schizophrenia. Completed, enrolled 55 participants across 1 site.
Detailed Summary
This study will determine whether using a pager improves medication adherence in people with schizophrenia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2006
First PostedOct 2006
Primary CompletionDec 2009
TodayJul 2026
First PostedOct 25, 2006
Enrollment StartApr 1, 2006
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 19.7 years ago
Interventions
2-way pagerdevice
Participants will receive messages daily to take their medication via a 2-way pager for 6 months. Once the message is received the participant will respond whether or not he/she took the medication and reason for not taking.
Treatment as usualbehavioral
Participants will receive treatment as usual.